MCAM and endometrial cancer: Coinjection of Ishikawa cells and CD146+CAFs significantly promoted the growth of endometrial cancer compared with injection of Ishikawa, Ishikawa + NF or Ishikawa + CD146−CAFs (Fig. 6A, B).